SCHEMBL6979147

SCHEMBL6979147

S=Cc1nccc(Oc2ccccc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
HTT P42858 1/20 0.42
LOXL2 Q9Y4K0 2/20 0.41
LOX P28300 1/20 0.41
BCAT2 O15382 1/20 0.40
MAP4K4 O95819 1/20 0.39
PLK4 O00444 1/20 0.39
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GLA P06280 1/20 0.37
LTA4H P09960 3/20 0.37
TSHR P16473 1/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
MAPK1 P28482 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
HAO1 Q9UJM8 1/20 0.36
GPR39 O43194 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL190518 0.74 PLAAT3 (0.48) ALDH1A1HTTLOXL2LOXBCAT2
SCHEMBL4272019 0.74 ALDH1A1 (0.47) ALDH1A1HTTLOXL2LOXBCAT2
SCHEMBL7041105 0.73 HTT (0.50) ALDH1A1HTTLOXL2LOXBCAT2
SCHEMBL7469887 0.73 HTT (0.46) ALDH1A1HTTLOXL2LOXBCAT2
SCHEMBL12813082 0.73 POLB (0.54) ALDH1A1HTTLOXL2LOXBCAT2
SCHEMBL7041110 0.73 ALDH1A1 (0.46) ALDH1A1HTTLOXL2LOXBCAT2
SCHEMBL8390081 0.72
SCHEMBL5119716 0.71 MAPK1 (0.59) ALDH1A1HTTLOXL2LOXNPC1
SCHEMBL30048005 0.70 POLB (0.51) ALDH1A1HTTLOXL2LOXBCAT2
SCHEMBL2521152 0.70 LTA4H (0.58) ALDH1A1HTTBCAT2MAP4K4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0862560-B1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LTD (GB) 2003-04-02 EP disclosed
US-6235746-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATIVE AGENT CELLTECH THERAPEUTICS, LIMITED (GB) 2001-05-22 US disclosed
US-5958935-A Substituted 2-anilinopyrimidines useful as protein kinase inhibitors CELLTECH THERAPEUTICS LIMITED (GB) 1999-09-28 US disclosed
EP-0862560-A1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1998-09-09 EP disclosed
WO-1997019065-A1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1997-05-29 WO disclosed